Utilization of TLR2 agonist Pam2Cys as adjuvant to facilitate the development of Staphylococcus aureus and Respiratory Syncytial Virus subunit vaccines Contract uri icon

Overview

Grant awarded by

  • MEDIMMUNE LLC

Awards

Time

Date/time interval

  • 2013 - 2015